TMC Life Sciences suspends GCEO; appoints temporary replacement


TMC Life Sciences Bhd group CEO Dr Melvin Heng Jun Li

PETALING JAYA: TMC Life Sciences Bhd has appointed director Dr Melvin Heng Jun Li as its group chief executive officer (GCEO) with immediate effect, following the suspension of Wan Nadiah Wan Mohd Abdullah Yaakob.

In a filing with Bursa Malaysia, the company said Wan Nadiah was also suspended as CEO of Thomson Hospitals Sdn Bhd, resulting in the powers, authorities and functions vested in her as the GCEO and CEO to be suspended with effect from Jan 29, 2024 until further announcement by the board.

The company added that it will continue its business as usual, while Heng, temporarily assumes the duties and functions of its GCEO.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
TMC Life Sciences , CEO , Melvin Heng Jun Li ,

Next In Business News

Light at the end of the tunnel
Understanding the warrant of distress
Are convention halls still good investments?
Ringgit likely to trade cautiously between RM4.09 and RM4.11 vs US dollar next week
Strong momentum seen for Vietnam equities
Asset managers in risk-on mode
Rising DRAM prices may hit consumers
Asia-Pacific ratings hold firm
HK’s lure for key IPO investors
Fewer stocks spur IPO hunt

Others Also Read